Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
22.72
-1.27 (-5.29%)
At close: Jul 16, 2026, 4:00 PM EDT
22.91
+0.19 (0.84%)
Pre-market: Jul 17, 2026, 4:47 AM EDT
Dyne Therapeutics Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Dyne Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $38.25. The average 1-year stock price forecast is 68.35% higher than the current stock price, while the lowest is $17 (-25.18%) and the highest is $50 (+120.07%).
Price Target: $38.25 (+68.35%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Dyne Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 12 | 12 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 16 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Maintains $50 | Buy | Maintains | $50 | +120.07% | Jul 1, 2026 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 26, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $44 | Buy | Reiterates | $44 | +93.66% | Jun 24, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $33 | Buy | Maintains | $33 | +45.25% | Jun 4, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $47 | Buy | Reiterates | $47 | +106.87% | Jun 4, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
52.71M
EPS This Year
-3.09
from -3.47
EPS Next Year
-3.00
from -3.09
EPS and Forward PE are based on non-GAAP adjusted numbers.